Stevenage, United Kingdom

Carlos Martinez Fleites

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2020-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos Martinez Fleites. Retrieved from https://idiyas.com/inventor/carlos-martinez-fleites

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Carlos Martinez Fleites

Introduction

Carlos Martinez Fleites is an accomplished inventor based in Stevenage, GB. He has made significant contributions to the field of biotechnology, particularly in the area of targeted protein degradation. With a total of 2 patents to his name, Fleites is recognized for his innovative approaches to controlling polypeptide sequences.

Latest Patents

Fleites' latest patents focus on a method of controlling the level of a polypeptide sequence. This involves administering a polypeptide sequence fused to a ubiquitin targeting protein that comprises a minimal degron structural motif. Notably, the polypeptide sequence includes a chimeric antigen receptor, making this invention particularly useful in cell and gene therapy where the activity of the chimeric antigen receptor needs to be regulated.

Career Highlights

Carlos Martinez Fleites is currently associated with GlaxoSmithKline Intellectual Property Development Limited. His work at this prominent company allows him to further his research and development efforts in innovative biotechnological solutions.

Collaborations

Fleites has collaborated with notable colleagues such as Lewis Lee Brayshaw and Michael Menteith Hann. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Carlos Martinez Fleites is a notable inventor whose work in targeted protein degradation has the potential to impact the fields of cell and gene therapy significantly. His contributions to biotechnology continue to pave the way for innovative solutions in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…